Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FHR2Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,382
Award facts
- Contract value 100% obligated
- $13,381.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,381.52 on January 21, 2026, by the Defense Logistics Agency (DLA) to supply Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 22, 2026. The order will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract reflects the critical role that AmerisourceBergen plays in the federal pharmaceutical supply chain, particularly in supporting military and veteran healthcare systems. DLA Troop Support Medical utilizes this expansive IDC vehicle to procure a diverse range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its extensive portfolio of pharmaceutical deliveries, positions the company as a key vendor for ensuring consistent access to essential medications for Defense Health Agency beneficiaries and other federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FHR2Y?
SPE2DR26FHR2Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FHR2Y worth?
The government has obligated $13,382 on SPE2DR26FHR2Y.
Is contract SPE2DR26FHR2Y an order under another contract?
Yes. SPE2DR26FHR2Y is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHR2Y competed?
The extent of competition for SPE2DR26FHR2Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award